From the Stroke Unit, Department of Neurology (M. Rubiera, A.G.-T., M.O.-G., D.C., M. Requena, J.P., D.R.-L., M.M., S.B., N.R.-V., J.J., M.D., E.S., C.A.M., M. Ribo), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.
Department of Neurorradiology (C.V., D.H., C.P., A.T.), Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona.
Stroke. 2020 Jun;51(6):1736-1742. doi: 10.1161/STROKEAHA.120.029212. Epub 2020 May 14.
Background and Purpose- Despite recanalization, almost 50% of patients undergoing endovascular treatment (EVT) experience poor outcome. We aim to evaluate the value of computed tomography perfusion as immediate outcome predictor postendovascular treatment. Methods- Consecutive patients receiving endovascular treatment who achieved recanalization (modified Thrombolysis in Cerebral Ischemia [mTICI] 2a-3) underwent computed tomography perfusion within 30 minutes from recanalization (CTPpost). Hypoperfusion was defined as the Tmax>6 second volume; hyperperfusion as visually increased cerebral blood flow/cerebral blood volume with reduced Tmax compared with unaffected hemisphere. Dramatic clinical recovery (DCR) was defined as 24-hour National Institutes of Health Stroke Scale score ≤2 or ≥8 points drop. Delayed recovery was defined as no-DCR with favorable outcome (modified Rankin Scale score 0-2) at 3 months. Results- We included 151 patients: median National Institutes of Health Stroke Scale score 16 (interquartile range, 10-21), median admission ASPECTS 9 (interquartile range, 8-10). Final recanalization was the following: mTICI2a 11 (7.3%), mTICI2b 46 (30.5%), and mTICI3 94 (62.3%). On CTPpost, 80 (52.9%) patients showed hypoperfusion (median Tmax>6 seconds: 4 cc [0-25]) and 32 (21.2%) hyperperfusion. There was an association between final TICI and CTPpost hypoperfusion(median Tmax>6: 91 [56-117], 15 [0-37.5], and 0 [0-7] cc, for mTICI 2a, 2b, and 3, respectively, <0.01). Smaller hypoperfusion volumes on CTPpost were observed in patients with DCR (0 cc [0-13] versus non-DCR 8 cc [0-56]; <0.01) or favorable outcome (modified Rankin Scale score 0-2: 0 cc [0-13] versus 7 [0-56] cc; <0.01). No associations were detected with hyperperfusion pattern. An hypoperfusion volume <3.5 cc emerged as independent predictor of DCR (OR, 4.1 [95% CI, 2.0-8.3]; <0.01) and 3 months favorable outcome (OR, 3.5 [95% CI, 1.6-7.8]; <0.01). Conclusions- Hypoperfusion on CTPpost constitutes an immediate accurate surrogate marker of success after endovascular treatment and identifies those patients with delayed recovery and favorable outcome.
背景与目的-尽管进行了血管内治疗(EVT),但仍有近 50%的患者预后不良。我们旨在评估 CT 灌注作为血管内治疗后即刻预后预测因子的价值。方法-连续接受血管内治疗且达到再通(改良脑梗死溶栓分级[mTICI]2a-3)的患者,在再通后 30 分钟内行 CT 灌注(CTPpost)。低灌注定义为 Tmax>6 秒的容积;高灌注定义为与未受累半球相比,脑血流/脑血容量增加,Tmax 降低。显著临床恢复(DCR)定义为 24 小时 NIHSS 评分≤2 分或降低≥8 分。延迟恢复定义为 3 个月时无 DCR 但预后良好(改良 Rankin 量表评分 0-2 分)。结果-我们纳入了 151 例患者:NIHSS 评分中位数为 16 分(四分位距 10-21),入院 ASPECTS 中位数为 9 分(四分位距 8-10)。最终再通情况如下:mTICI2a 11 例(7.3%),mTICI2b 46 例(30.5%),mTICI3 94 例(62.3%)。在 CTPpost 上,80 例(52.9%)患者出现低灌注(Tmax>6 秒的中位数:4cc[0-25]),32 例(21.2%)患者出现高灌注。最终 TICI 与 CTPpost 低灌注之间存在关联(Tmax>6 的中位数:mTICI2a 为 91[56-117],mTICI2b 为 15[0-37.5],mTICI3 为 0[0-7]cc,均<0.01)。DCR 患者的 CTPpost 低灌注容积较小(0cc[0-13]与非 DCR 患者 8cc[0-56],均<0.01),预后良好(改良 Rankin 量表评分 0-2 分)患者的 CTPpost 低灌注容积也较小(0cc[0-13]与 7cc[0-56],均<0.01)。未发现高灌注模式与预后之间存在关联。低灌注体积<3.5cc 是 DCR(OR,4.1[95%CI,2.0-8.3];<0.01)和 3 个月预后良好(OR,3.5[95%CI,1.6-7.8];<0.01)的独立预测因子。结论-CTPpost 上的低灌注是血管内治疗后成功的即时、准确的替代标志物,可识别出延迟恢复和预后良好的患者。